Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancer
Authors:
- 1 January 1989
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 24 (5) , 321-325
Abstract
Summary Since 1980, 75 patients with small-cell lung cancer (SCLC) have been entered into four consecutive studies of high-dose chemotherapy using autologous bone marrow transplantation (ABMT) to assist haematological recovery. In the first study, 25 patients were treated with cyclophosphamide (160–200 mg/kg) as the sole chemotherapy; in the second (26 patients), the cycle of high-dose cyclophosphamide (with or without 800–1,200 mg/m2 etoposide) was repeated as induction treatment. In the first study, response was high [14 complete responses (CR), 7 partial responses (PR)] but was not increased by repeating the cycle (15 CR, 8 PR), and survival was slightly worse in the second trial. In the third study, 15 patients were treated with doxorubicin, vincristine and etoposide for two cycles and then with 200 mg/kg cyclophosphamide. Although high-dose cyclophosphamide increased the complete response rate, the additional responses were short-lived. In the final study, an attempt was made to increase the initial CR rate by combination chemotherapy using carboplatin (400–600 mg/m2), etoposide (120 mg/ m2x4) and either high-dose cyclophosphamide (40 mg/kg x4) or melphalan (140 mg/m2). Although all nine patients responded, none underwent a CR. The long-term survival (up to 7 years) does not appear to be different from that in comparably selected cases treated with conventional chemotherapy.Keywords
This publication has 13 references indexed in Scilit:
- A mathematical model of drug resistance applied to treatment for small-cell lung cancer.Journal of Clinical Oncology, 1988
- Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study.Journal of Clinical Oncology, 1987
- Repeated high-dose cyclophosphamide administration in bone marrow transplantation: exposure to activated metabolitesCancer Chemotherapy and Pharmacology, 1987
- High-dose intensification therapy with autologous bone marrow support for limited small-cell bronchogenic carcinoma.Journal of Clinical Oncology, 1986
- High-dose cyclophosphamide with autologous bone marrow rescue after conventional chemotherapy in the treatment of small cell lung carcinomaCancer Chemotherapy and Pharmacology, 1985
- PROGNOSTIC-SIGNIFICANCE OF LABORATORY PARAMETERS MEASURED AT DIAGNOSIS IN SMALL CELL-CARCINOMA OF THE LUNG1985
- High-dose etoposide as single-agent chemotherapy for small cell carcinoma of the lung.1983
- High-dose cyclophosphamide with autologous marrow transplantation for small cell carcinoma of the bronchusCancer Chemotherapy and Pharmacology, 1983
- Cisplatin, adriamycin, and etoposide (cav) for remission induction of small-cell bronchogenic carcinoma. Evaluation of efficacy and toxicity and pilot study of a “late intensification” with autologous bone-marrow rescueCancer, 1982
- High-dose cyclophosphamide with autologous marrow transplantation as initial treatment of small cell carcinoma of the bronchusCancer Chemotherapy and Pharmacology, 1982